BackBioNeutra Global Overview

BioNeutra Global Current Assets

Track BioNeutra Global's current assets ($5.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$5.26M
↓ 19.31% YoYΔ $-1.26M vs prior year quarter

Peer trimmed avg / median

Loading

BioNeutra Global Current Assets History

Loading

BioNeutra Global vs. peers: Current Assets Comparison

Loading

BioNeutra Global Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioNeutra Global (BGACF) FAQ

BioNeutra Global posts a current assets of $5.3M as of September 2024. That compares with $6.5M in the prior-year period — down 19.3% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, BioNeutra Global's current assets was $6.5M. The latest reading is $5.3M — a 19.3% year-over-year decrease (period ending September 2024). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of BioNeutra Global's financial statement story. At $5.3M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for BGACF's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioNeutra Global's other metric pages and overview cover the third.